Stockholders' Equity |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Stockholders' Equity Note [Abstract] | Â |
| Stockholders' Equity |
10. Stockholders’ Equity As of March 31, 2025, there were 1,000,000,000 shares of common stock authorized, 330,987,359 shares of common stock issued, and 324,814,438 shares of common stock outstanding. As of December 31, 2024, there were 1,000,000,000 shares of common stock authorized, 329,866,784 shares of common stock issued, and 323,693,863 shares of common stock outstanding. As of March 31, 2025 and December 31, 2024, there were 5,000,000 shares of preferred stock authorized and none were issued or outstanding. We use the cost method to account for treasury stock. As of March 31, 2025 and December 31, 2024, we had 6,172,921 shares of treasury stock. As of March 31, 2025 and December 31, 2024, the cost of treasury stock included in additional paid-in capital in the accompanying consolidated balance sheets was $28,895. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|